Melrose et al., 2010 - Google Patents
Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic miceMelrose et al., 2010
View PDF- Document ID
- 1141336978317626749
- Author
- Melrose H
- Dächsel J
- Behrouz B
- Lincoln S
- Yue M
- Hinkle K
- Kent C
- Korvatska E
- Taylor J
- Witten L
- Liang Y
- Beevers J
- Boules M
- Dugger B
- Serna V
- Gaukhman A
- Yu X
- Castanedes-Casey M
- Braithwaite A
- Ogholikhan S
- Yu N
- Bass D
- Tyndall G
- Schellenberg G
- Dickson D
- Janus C
- Farrer M
- Publication year
- Publication venue
- Neurobiology of disease
External Links
Snippet
Mutations in the Leucine Rich Repeat Kinase 2 (LRRK2) gene, first described in 2004 have now emerged as the most important genetic finding in both autosomal dominant and sporadic Parkinson's disease (PD). While a formidable research effort has ensued since the …
- 102100002485 MAPT 0 title abstract description 91
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Melrose et al. | Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice | |
| Jenniches et al. | Anxiety, stress, and fear response in mice with reduced endocannabinoid levels | |
| Weeber et al. | The role of mitochondrial porins and the permeability transition pore in learning and synaptic plasticity | |
| Longo et al. | Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging | |
| Andreasson et al. | Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice | |
| Dave et al. | Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease | |
| Tsika et al. | Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration | |
| Logge et al. | Role of Abca7 in mouse behaviours relevant to neurodegenerative diseases | |
| Swarnkar et al. | Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease | |
| Zhang et al. | Loss of glutamic acid decarboxylase (Gad67) in Gpr88-expressing neurons induces learning and social behavior deficits in mice | |
| Bisaz et al. | Age-related cognitive impairments in mice with a conditional ablation of the neural cell adhesion molecule | |
| Maurice et al. | Amyloid toxicity is enhanced after pharmacological or genetic invalidation of the σ1 receptor | |
| Sotiriou et al. | Selective noradrenergic vulnerability in alpha-synuclein transgenic mice | |
| Keil et al. | Genetic mutations in Ca2+ signaling alter dendrite morphology and social approach in juvenile mice | |
| Guilloux et al. | Characterization of 5-HT1A/1B−/− mice: An animal model sensitive to anxiolytic treatments | |
| Kojima et al. | Genetic disruption of the alternative splicing of drebrin gene impairs context-dependent fear learning in adulthood | |
| Akahoshi et al. | Frequent spontaneous seizures followed by spatial working memory/anxiety deficits in mice lacking sphingosine 1-phosphate receptor 2 | |
| Lebrun et al. | HDAC inhibitor ameliorates behavioral deficits in Mecp2308/y mouse model of Rett syndrome | |
| Moriguchi et al. | Reduced CaM kinase II and CaM kinase IV activities underlie cognitive deficits in NCKX2 heterozygous mice | |
| Branco et al. | Vesicular monoamine transporter 2 mediates fear behavior in mice | |
| JP7012310B2 (en) | Mental illness model animals and their manufacturing methods | |
| Shahani et al. | Forebrain depletion of Rheb GTPase elicits spatial memory deficits in mice | |
| Azkona et al. | In vivo effects of APP are not exacerbated by BACE2 co-overexpression: behavioural characterization of a double transgenic mouse model | |
| Yu et al. | Partial rescue of neonatal lethality of Dhcr7 null mice by a nestin promoter-driven DHCR7 transgene expression | |
| US20200215204A1 (en) | Early-onset parkinson's disease model: (d331y) pla2g6 knockin model, platform and method for drug screening, and kit of detection |